Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

About Vaccitech

Vaccitech is tracked on 100Xfounder as a healthcare company, founded in 2016, based in London, England, United Kingdom, currently mapped to the Ipo stage. Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

Profile snapshot: Founders linked: Vaccitech Team. Funding tracked: $290.00M. Hiring focus: Open Roles. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

  • Vaccitech appears in the 100Xfounder startup directory import feed.

Why it Matters

Vaccitech is worth tracking because its funding history is already mapped here, including a $290.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Vaccitech Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $290.00MLast Round: IPO Sequoia, Post-IPO, $290M valuationAll Rounds: 1
  • IPO | Sequoia, Post-IPO, $290M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: June 1, 2026

Vaccitech research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

  • Founders covered

    Vaccitech Team

  • Market position

    Healthcare | Ipo | London, England, United Kingdom

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $290.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Vaccitech.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Vaccitech

Common questions people ask about this profile.

What is Vaccitech?

Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

Who founded Vaccitech?

Vaccitech is associated with Vaccitech Team on 100Xfounder.

Where is Vaccitech located?

Vaccitech is listed in London, England, United Kingdom.

What stage is Vaccitech in?

Vaccitech is currently mapped to Ipo. Funding context: Sequoia, Post-IPO, $290M valuation

What is the latest funding round of Vaccitech?

Vaccitech's latest tracked round is IPO Sequoia, Post-IPO, $290M valuation. Total tracked rounds: 1.

Is Vaccitech hiring now?

Vaccitech hiring status: Open Roles.

What technologies does Vaccitech use?

Vaccitech is associated with Python, GCP, BigQuery, and React.

Is Vaccitech verified on 100Xfounder?

Yes. Vaccitech is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with Vaccitech founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.